Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to further test a combination chemotherapy regimen for the
treatment of squamous cell carcinoma of the head and neck and to see if the addition of
supportive medicine can help reduce the side effects of these drugs.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital Sanofi